TKG Therapeutics, Inc.
PrivateLast Round
Seed
Jan 31, 2024
Est. Valuation
$2.04M
Total Funding Raised
$1.02M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
TKG Therapeutics, Inc. is a biotechnology company that develops nucleic acid-based cancer immunotherapies and proprietary immersion solid-phase synthesis technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TKG Therapeutics, Inc. Comparables
Compare TKG Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| e-NA Biotec Inc. | 78% | |
| Liid Pharmaceuticals, Inc. | 72% | |
| OncoNano Medicine | 72% |
TKG Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 31, 2024 |
TKG Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UntroD Capital Japan Inc. | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 93% MoM.
- Jul 26, 2026
Monthly visitors increased 2239% MoM, from 23 to 538.
Recent news
Latest coverage and updates
- attends_eventSep 4, 2026
Tkg Na attended event ICC SUMMIT KYOTO 2026 on Sep 2nd '26.
- attends_eventSep 4, 2026
Tkg Na attended event DEEPTECH CATAPULT on Sep 2nd '26.
TKG Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about TKG Therapeutics, Inc.'s valuation, stock price, and market status.
Is TKG Therapeutics, Inc. a public or private company?
TKG Therapeutics, Inc. is a private company.
What is the current stock price of TKG Therapeutics, Inc.?
TKG Therapeutics, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is TKG Therapeutics, Inc. worth (valuation)?
TKG Therapeutics, Inc.'s valuation is estimated at $2.0M based on funding round data.
Can I buy TKG Therapeutics, Inc. stock?
TKG Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was TKG Therapeutics, Inc.'s last funding round?
TKG Therapeutics, Inc.'s most recent funding round was Seed on January 31, 2024.
Who are the main investors in TKG Therapeutics, Inc.?
Key investors in TKG Therapeutics, Inc. include UntroD Capital Japan Inc..
Will TKG Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for TKG Therapeutics, Inc..
How can I track TKG Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TKG Therapeutics, Inc.'s secondary market activity and sign up for updates.